Key Highlights

● Astera Labs closed at $285.82 on October 16, trading below the analyst target.

● The consensus 12-month price target is $391.77, implying about 37.1% upside.

● Analysts are split 18 Buy, 8 Hold, and 0 Sell on the stock.

● Targets range from $190 to $500 across 26 analysts.

Astera Labs (NASDAQ:ALAB) closed at $285.82 on Friday October 16, 2026, the latest close at the time of writing. The consensus analyst price target is $391.77, which implies implied upside of about 37.1% from that price. The shares are listed on the Nasdaq and the consensus rating is Buy. Investors are watching the stock because of recent analyst target changes and an upcoming results date, both discussed below.

What Is the Latest Analyst Price Target?

Across 26 analysts, the mean target is $391.77 and the median is $425.00. The highest target is $500 and the lowest is $190. The consensus data was last updated around October 16, 2026, so it may not reflect later developments, and the share price is the 16 October close. The consensus target suggests the stock trades below the average analyst valuation. The median ($425) is notably above the mean ($391.77), suggesting a few low targets, such as $190, pull the average down. Price targets are forecasts, not guarantees, and analysts typically set them with a 12-month horizon.

What Are Analysts Saying?

The rating split is 18 Buy (11 Strong Buy, 7 Buy), 8 Hold, 0 Sell. Recent actions include the following. Stifel maintained Buy with a $460 target on October 16, 2026, Northland downgraded the stock to Market Perform (Hold) on 9 October with no target, citing valuation, Fubon initiated at Buy with $500 on 30 September, and Citi lifted its target from $315 to $430 on 6 August. Sources differ in how they classify ratings, so the split above follows the data provider's own groupings and the figures should be treated as indicative.

Astera Labs launched its Aries 7 PCIe 7 signal-conditioning portfolio and joined Lumentum and Corning in an optical PCIe connectivity demonstration at the 2026 OCP Global Summit.

What Could Help the Stock Reach the Price Target?

If the consensus proves accurate, the main supports would be adoption of PCIe 7 and optical connectivity products, AI rack-scale demand, and a results update that supports the growth narrative. For the shares to move towards the average target, the company would generally need to deliver results and guidance that meet or exceed what analysts currently expect, and market conditions for the sector would need to remain supportive. None of this is assured.

What Could Prevent the Stock Reaching the Target?

The main risks include valuation concerns such as those cited by Northland, a limited track record as a listed company, and the fact that the shares fell 5.35% on the last trading day. Analyst targets are frequently revised after earnings, and a change in sector sentiment, interest-rate expectations or broader market conditions could shift valuations quickly. A target is an opinion at a point in time and the actual share price may be materially different.

What Should Investors Watch Next?

The key near-term event is third-quarter 2026 results, scheduled for November 3, 2026. Investors may also watch for further target revisions following that report, any change in the Buy, Hold and Sell mix, and management commentary on demand and margins.

A Target That Assumes a Lot

At $285.82, Astera Labs trades below its $391.77 consensus target, a gap of 37.1%, with a Buy consensus from 26 analysts.